117 related articles for article (PubMed ID: 11092697)
1. The length of the CTLA-4 microsatellite (AT)N-repeat affects the risk for type 1 diabetes. Diabetes Incidence in Sweden Study Group.
Lowe RM; Graham J; Sund G; Kockum I; Landin-Olsson M; Schaefer JB; Törn C; Lernmark A; Dahlquist G
Autoimmunity; 2000 Oct; 32(3):173-80. PubMed ID: 11092697
[TBL] [Abstract][Full Text] [Related]
2. No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population.
Ban Y; Taniyama M; Tozaki T; Yanagawa T; Yamada S; Maruyama T; Kasuga A; Tomita M; Ban Y
Autoimmunity; 2001; 34(1):39-43. PubMed ID: 11681491
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry.
Van der Auwera BJ; Vandewalle CL; Schuit FC; Winnock F; De Leeuw IH; Van Imschoot S; Lamberigts G; Gorus FK
Clin Exp Immunol; 1997 Oct; 110(1):98-103. PubMed ID: 9353155
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies.
Kikuoka N; Sugihara S; Yanagawa T; Ikezaki A; Kim HS; Matsuoka H; Kobayashi Y; Wataki K; Konda S; Sato H; Miyamoto S; Sasaki N; Sakamaki T; Niimi H; Murata M
Clin Endocrinol (Oxf); 2001 Nov; 55(5):597-603. PubMed ID: 11894970
[TBL] [Abstract][Full Text] [Related]
5. [Association between type 1 diabetes and polymorphism of the CTLA-4 gene in a Tunisian population].
Kamoun Abid H; Hmida S; Smaoui N; Kaabi H; Abid A; Chaabouni H; Boukef K; Nagati K
Pathol Biol (Paris); 2001 Dec; 49(10):794-8. PubMed ID: 11776689
[TBL] [Abstract][Full Text] [Related]
6. CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody.
Abe T; Yamaguchi Y; Takino H; Fujita N; Yamauchi-Degawa M; Ozaki M; Yamakawa K; Sera Y; Sakamaki H; Uotani S; Kawasaki E; Awata T; Yamasaki H; Eguchi K
Diabet Med; 2001 Sep; 18(9):726-31. PubMed ID: 11606170
[TBL] [Abstract][Full Text] [Related]
7. Markers for risk of type 1 diabetes in relatives of Alsacian patients with type 1 diabetes.
Ongagna JC; Sapin R; Pinget M; Belcourt A
Int J Exp Diabetes Res; 2002; 3(1):1-9. PubMed ID: 11900275
[TBL] [Abstract][Full Text] [Related]
8. Association of CTLA-4 polymorphism with positive anti-GAD antibody in Japanese subjects with type 1 diabetes mellitus.
Hayashi H; Kusaka I; Nagasaka S; Kawakami A; Rokkaku K; Nakamura T; Saito T; Higashiyama M; Honda K; Ishikawa SE
Clin Endocrinol (Oxf); 1999 Dec; 51(6):793-9. PubMed ID: 10619986
[TBL] [Abstract][Full Text] [Related]
9. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population.
Awata T; Kurihara S; Iitaka M; Takei S; Inoue I; Ishii C; Negishi K; Izumida T; Yoshida Y; Hagura R; Kuzuya N; Kanazawa Y; Katayama S
Diabetes; 1998 Jan; 47(1):128-9. PubMed ID: 9421386
[No Abstract] [Full Text] [Related]
10. The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus.
Lee YJ; Lo FS; Shu SG; Wang CH; Huang CY; Liu HF; Wu CC; Yang TY; Chang JG
J Pediatr Endocrinol Metab; 2001 Apr; 14(4):383-8. PubMed ID: 11327371
[TBL] [Abstract][Full Text] [Related]
11. The study of CTLA-4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population.
Guja C; Marshall S; Welsh K; Merriman M; Smith A; Todd JA; Ionescu-Tîrgoviste C
J Cell Mol Med; 2002; 6(1):75-81. PubMed ID: 12003670
[TBL] [Abstract][Full Text] [Related]
12. CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population.
Chistiakov DA; Savost'anov KV; Nosikov VV
BMC Genet; 2001; 2():6. PubMed ID: 11286636
[TBL] [Abstract][Full Text] [Related]
13. Association study of the NRAMP1 gene promoter polymorphism and early-onset type 1 diabetes.
Bassuny WM; Ihara K; Matsuura N; Ahmed S; Kohno H; Kuromaru R; Miyako K; Hara T
Immunogenetics; 2002 Jul; 54(4):282-5. PubMed ID: 12136340
[TBL] [Abstract][Full Text] [Related]
14. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population.
Ihara K; Ahmed S; Nakao F; Kinukawa N; Kuromaru R; Matsuura N; Iwata I; Nagafuchi S; Kohno H; Miyako K; Hara T
Immunogenetics; 2001 Aug; 53(6):447-54. PubMed ID: 11685455
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between CTLA-4 gene polymorphism and IDDM in Japanese subjects.
Yanagawa T; Maruyama T; Gomi K; Taniyama M; Kasuga A; Ozawa Y; Terauchi M; Hirose H; Maruyama H; Saruta T
Autoimmunity; 1999; 29(1):53-6. PubMed ID: 10052685
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults.
Cosentino A; Gambelunghe G; Tortoioli C; Falorni A
Ann N Y Acad Sci; 2002 Apr; 958():337-40. PubMed ID: 12021137
[TBL] [Abstract][Full Text] [Related]
17. A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis.
Barton A; Myerscough A; John S; Gonzalez-Gay M; Ollier W; Worthington J
Rheumatology (Oxford); 2000 Jan; 39(1):63-6. PubMed ID: 10662875
[TBL] [Abstract][Full Text] [Related]
18. Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease.
Takara M; Komiya I; Kinjo Y; Tomoyose T; Yamashiro S; Akamine H; Masuda M; Takasu N
Diabetes Care; 2000 Jul; 23(7):975-8. PubMed ID: 10895849
[TBL] [Abstract][Full Text] [Related]
19. CTLA4 variants in type 1 diabetes: some stirrups serve better backing endocrine autoimmunity.
Badenhoop K
Clin Endocrinol (Oxf); 2000 Feb; 52(2):139-40. PubMed ID: 10671938
[No Abstract] [Full Text] [Related]
20. No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM.
Djilali-Saiah I; Larger E; Harfouch-Hammoud E; Timsit J; Clerc J; Bertin E; Assan R; Boitard C; Bach JF; Caillat-Zucman S
Diabetes; 1998 Jan; 47(1):125-7. PubMed ID: 9421385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
